Blog

Better late than never? The U.S. Food and Drug Administration (FDA) will hold a gathering of scientific and clinical experts to discuss whether metal-on-metal (MoM) artificial hip systems should undergo more rigorous scientific scrutiny before they are implanted in U.S. patients, which sounds infinitely reasonable. On Thursday, March 29, the […]

The U.S. Food and Drug Administration (FDA) has revised its recommendations for the popular antidepressant, Celexa (citalopram hydrobromide). Last August, the FDA warned Celexa should be limited to doses no greater than 40 mg per day because of a risk of abnormal electrical activity in the heart known as Torsade […]

Johnson & Johnson (J&J) rarely responds to negative news, which it’s been experiencing a lot of lately, usually relying on the news cycles to wash away unfavorable reports. But in an unusual move, a J&J spokesman recently did defend the company from the latest blow – that the health care […]

It’s little known and rarely applied but the Park doctrine does allow the U.S. government to file a misdemeanor criminal charge against corporate officials even if they didn’t intend to violate any law. The law is based on the conviction of a Mr. John Park, who owned Acme Markets, a […]

On March 26, 2012, Searcy Denney filed two additional individual lawsuits against Bayer Corporation, the manufacturer of Yasmin and Yaz. One of the new cases was filed on behalf of a married Texas woman who works as a Head Start teacher.  She started taking Yasmin in 2008, and quickly developed […]

Johnson & Johnson knew about at least some of the serious problems related to their DePuy ASR hip implant, known as metal-on-metal (MOM) implants,  before they ever started alerting consumers and it appears they may have known about it even before they asked the FDA to approve the device through […]

If I sell you a product and make a profit from selling that product; do I owe a duty to you for the reasonable safety of that product? Most reasonable people would agree that a company should not be permitted to simply ignore the safety of products it profits from […]

The Mass Tort Unit at Searcy Denney recently filed an individual lawsuit against Davol, Inc., a division of C.R. Bard. in Broward County on behalf of a Margate, Florida resident.  This South Florida woman underwent a hernia repair surgery in November of 2005 and was implanted with a Composix Kugel […]

March has been a busy month for new filings in the national litigation efforts involving bisphosphonate drug-induced femur fractures.  Currently, there are coordinated state court proceedings pending in Atlantic City, New Jersey as well as Southern California involving the manufacturers of Fosamax, Boniva, and other osteoporosis drugs.  There are also […]

A recently unsealed complaint filed by whistleblower Helen Ge reveals that over four years, Takeda Pharmaceuticals failed to report to the FDA congestive heart failure cases in patients taking Actos. Takeda manufactures the Type II diabetes drug Actos. Actos is the third in a long line of failed Type II […]